22 Oct

Pharma speaks loud and clear on need for 101 changes, but consensus for reform remains elusive

The USPTO must issue a report on the Section 101 state of play next spring, but lawmakers will be hard pressed to reconcile deeply divided opinion on patent eligibility among stakeholders

Angela Morris

Author | Deputy editor

[email protected]

Angela Morris